Breast Cancer Research and Treatment

, Volume 24, Issue 3, pp 209–218 | Cite as

Type IV collagenases in invasive tumors

  • Karl Tryggvason
  • Matti Höyhtyä
  • Charles Pyke
Article

Summary

The matrix metalloproteinases appear to be elevated in tumors with metastatic potential, and may well be involved in penetration of the basement membrane and degradation of extracellular proteins including type IV collagen. An imbalance between the 72 kDa and 92 kDa type IV collagenases and the associated tissue inhibitors of these metalloproteinases (TIMPs) may therefore have a role in the invasive phenotype. Cultured tumor cells with invasive potential secrete both type IV collagenases, though in tumors there is some evidence that the 72 kDa form at least may be produced by stromal cells at the invading tumor front rather than primarily by the tumor cells themselves, while the 92 kDa form may be synthesized in macrophages near the front. These collagenases are elevated in invasive as compared within situ tumor components, but their specific roles and prognostic significance are not yet established.

Key words

extracellular matrix invasion metalloproteinases TIMPs type IV collagenases 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Woessner JF: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145–2154, 1991PubMedGoogle Scholar
  2. 2.
    Tryggvason K, Höyhtyä M, Salo T: Proteolytic degradation of extracellular matrix in tumor invasion. Biochim Biophys Acta 907:191–217, 1987PubMedGoogle Scholar
  3. 3.
    Liotta LA, Steeg P, Stetler-Stevenson W: Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64:327–336, 1991PubMedGoogle Scholar
  4. 4.
    Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer JL, Kronberger A, He C, Bauer EA, Goldberg GI: H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem 263:6579–6587, 1988PubMedGoogle Scholar
  5. 5.
    Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI: SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 264:17213–17221, 1989PubMedGoogle Scholar
  6. 6.
    Huhtala P, Eddy RL, Fan YS, Byers MG, Shows TB, Tryggvason K: Completion of the primary structure of the human type IV collagenase preproenzyme and assignment of the gene (CLG4) to the q21 region of chromosome 16. Genomics 6:554–559, 1990PubMedGoogle Scholar
  7. 7.
    Huhtala P, Tuuttila A, Chow L, Lohi J, Keski-Oja J, Tryggvason K: Complete structure of the human gene for 92-kDa type IV collagenase: Divergent regulation of expression for the 92-kDa and 72-kDa enzyme genes in HT-1080 cells. J Biol Chem 266:16485–16490, 1991PubMedGoogle Scholar
  8. 8.
    Fessler L, Duncan K, Fessler JH, Salo T, Tryggvason K: Characterization of the procollagen IV cleavage products produced by a specific tumor collagenase. J Biol Chem 259:9783–9789, 1984PubMedGoogle Scholar
  9. 9.
    Murphy G, Ward R, Hembry RM, Reynolds JJ, Kühn K, Tryggvason K: Characterization of gelatinase from pig polymorphonuclear leukocytes. Biochem J 258: 463–472, 1989PubMedGoogle Scholar
  10. 10.
    Goldberg GI, Wilhelm SM, Kronberger A, Bauer EA, Grant GA, Eisen AZ: Human fibroblast collagenase: Complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem 261:6600–6605, 1986PubMedGoogle Scholar
  11. 11.
    Hibbs MS, Hasty KA, Seyer JM, Kang AH, Mainardi CL: Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J Biol Chem 260:2493–2500, 1985PubMedGoogle Scholar
  12. 12.
    Hasty KA, Pourmotabbed TF, Goldberg GI, Thompson JP, Spinella DG, Stevens RM, Mainardi CL: Human neutrophil collagenase: A distinct gene product with homology to other matrix metalloproteinases. J Biol Chem 265:11421–11424, 1990PubMedGoogle Scholar
  13. 13.
    Matrisian LM, Glaichenhaus N, Gesnel M-C, Breathnach R: Epidermal growth factor and oncogenes induce transcription of the same cellular mRNA in rat fibroblasts. EMBO J 4:1435–1440, 1985PubMedGoogle Scholar
  14. 14.
    Whitham SE, Murphy G, Angel P, Rahmsdorf H-J, Smith BJ, Lyons A, Harris T, Reynolds JJ, Herrlich P, Docherty AJP: Comparison of human stromelysin and collagenase by cloning and sequence analysis. Biochem J 240:913–916, 1987Google Scholar
  15. 15.
    Breathnach R, Matrisian LM, Gesnel M-C, Staub A, Leroy P: Sequences coding for part of oncogene-induced transin are highly conserved in a related rat gene. Nucleic Acid Res 15:1139–1151, 1987PubMedGoogle Scholar
  16. 16.
    Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limocher JM, Podhajcer OL, Chenard MP, Rio MC, Chambon P: A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348:699–704, 1990PubMedGoogle Scholar
  17. 17.
    Woessner JF, Taplin CJ: Purification and properties of a small latent matrix metalloproteinase of the rat uterus. J Biol Chem 263:16918–16925, 1988PubMedGoogle Scholar
  18. 18.
    Quantin B, Murphy G, Breathnach R: Pump-1 codes for a protein with characteristics similar to those of classical collagenase family members. Biochem 28:5327–5334, 1989Google Scholar
  19. 19.
    Grant GA, Eisen AZ, Marmer BL, Roswit WT, Goldberg GI: The activation of human skin fibroblast procollagenase. J Biol Chem 262:5886–5889, 1987PubMedGoogle Scholar
  20. 20.
    Fridmen R, Fuerst TR, Bird RE, Höyhtyä M, Oelkuct M, Kraus S, Komarek D, Liotta LA, Berman ML, Stetler-Stevenson WG: Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions. J Biol Chem 267:15398–15405, 1992PubMedGoogle Scholar
  21. 21.
    Woolley DE, Glanville RW, Crossley MJ, Evanson JM: Purification of rheumatoid collagenase and its action on soluble and insoluble collagen. Eur J Biochem 54:611–622, 1975PubMedGoogle Scholar
  22. 22.
    McCroskery PA, Richards JF, Harris ED Jr: Purification and characterization of a collagenase extracted from rabbit tumours. Biochem J 152:131–142, 1975PubMedGoogle Scholar
  23. 23.
    Birkedal-Hansen H, Cobb CM, Taylor RE, Fullmer HM: Procollagenase from bovine gingiva. Biochim Biophys Acta 429:229–238, 1976PubMedGoogle Scholar
  24. 24.
    Docherty AJP, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJR, Murphy G, Reynolds JJ: Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 318:66–69, 1985PubMedGoogle Scholar
  25. 25.
    Gasson JC, Golde DW, Kaufman SE, Westbrook CA, Hewick RM, Kaufman RJ, Wong GG, Temple PA, Leary AC, Brown EL, Orr EC, Clark SC: Molecular characterization and expression of the gene encoding human erythroid-potentiating activity. Nature 315: 768–771, 1985PubMedGoogle Scholar
  26. 26.
    Stetler-Stevenson WG, Krutzsch HC, Wacher MP, Margulies IMK, Liotta LA: The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation. J Biol Chem 264:1353–1356, 1989PubMedGoogle Scholar
  27. 27.
    Lu X, Levy M, Weinstein B, Santella TM: Immunological quantitation of levels of tissue inhibitor of metalloproteinase-1 in human colon cancer. Cancer Res 51:6231–6235, 1991PubMedGoogle Scholar
  28. 28.
    Stetler-Stevenson WG, Brown PD, Onisto M, Levy AT, Liotta LA: Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 265:13933–13938, 1990PubMedGoogle Scholar
  29. 29.
    Alexander CM, Werb Z: Targeted disruption of the tissue inhibitor of metalloproteinases gene increases the invasive behavior of primitive mesenchymal cells derived from embryonic stem cellsin vitro. J Cell Biol 118:727–739, 1992PubMedGoogle Scholar
  30. 30.
    DeClerck YA, Yean T-D, Lu HS, Ting J, Langley KE: Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor MI/TIMP-2. J Biol Chem 266:3893–3899, 1991PubMedGoogle Scholar
  31. 31.
    DeClerck YA, Perez N, Shimada H, Boone TC, Langley KE, Taylor SM: Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 52:701–708, 1992PubMedGoogle Scholar
  32. 32.
    Reponen P, Sahlberg C, Huhtala P, Hurskainen T, Thesleff I, Tryggvason K: Molecular cloning of murine 70-kDa type IV collagenase and its expression during mouse development. J Biol Chem 267:7856–7862, 1992PubMedGoogle Scholar
  33. 33.
    Nakajima M, Welch DR, Belloni PN, Nicholson GL: Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adeno-carcinoma cell clones of differing metastatic potentials. Cancer Res 47:4869–4876, 1987PubMedGoogle Scholar
  34. 34.
    Lyons JG, Birkedal-Hansen B, Moore WGI, O'Grady RL, Birkedal-Hansen H: Characteristics of a 95-kDa matrix metalloproteinase produced by mammary carcinoma cells. Biochemistry 30:1449–1456, 1991PubMedGoogle Scholar
  35. 35.
    Barsky SH, Grossman DA, Bhuta S: Desmoplastic basal cell carcinomas possess unique basement membrane-degrading properties. J Invest Dermatol 88:324–329, 1987PubMedGoogle Scholar
  36. 36.
    Monteagudo C, Merino MJ, San-Juan J, Liotta LA, Stetler-Stevenson WG: Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. Am J Pathol 136:585–592, 1990PubMedGoogle Scholar
  37. 37.
    Daidone MG, Silvestrini R, D'Errico A, Di Fronzo G, Benini E, Mancini AM, Garbisa S, Liotta LA, Grigioni WF: Laminin receptors, collagenase IV and prognosis in node-negative breast cancers. Int J Cancer 48:529–532, 1991PubMedGoogle Scholar
  38. 38.
    D'Errico A, Garbisa S, Liotta LA, Castronovo V, Stetler-Stevenson WG, Grigioni WF: Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression. Mod Pathol 4:239–246, 1991PubMedGoogle Scholar
  39. 39.
    Levy AT, Cioce V, Sobel ME, Garbisa S, Grigioni WF, Liotta LA, Stetler-Stevenson WG: Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. Cancer Res 51:439–444, 1991PubMedGoogle Scholar
  40. 40.
    Autio-Harmaninen H, Karttunen T, Hurskainen T, Höyhtä M, Kauppila A, Tryggvason K: Expression of 72 kDa type IV collagenase in benign and malignant ovarian tumors. SubmittedGoogle Scholar
  41. 41.
    Grigioni WF, Garbisa S, D'Errico A, Baccarini P, Stetler-Stevenson WG, Liotta LA, Mancini AM: Evaluation of hepatocellular carcinoma aggressiveness by a panel of extracellular matrix antigens. Am J Pathol 138:647–654, 1991PubMedGoogle Scholar
  42. 42.
    Ura H, Bonfil RD, Reich R, Reddel R, Pfeifer A, Harris CC, Klein-Szanto AJP: Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells. Cancer Res 49:4615–4621, 1989PubMedGoogle Scholar
  43. 43.
    Ohori NP, Yousem SA, Griffin J, Stanis K, Stetler-Stevenson WG, Colby TV, Sonmez-Alpan E: Comparison of extracellular matrix antigens in subtypes of bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma. Am J Surg Pathol 16:675–686, 1992PubMedGoogle Scholar
  44. 44.
    Pyke C, Ralfkiaer E, Huhtala P, Hurskainen T, Danø K, Tryggvason K: Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers byin situ hybridization. Cancer Res 52:1336–1341, 1992PubMedGoogle Scholar
  45. 45.
    Poulsom R, Pignatelli M, Stetler-Stevenson WG, Liotta LA, Wright PA, Jeffrey RE, Longcroft JM, Rogers L, Stamp GWH: Stromal expression of 72 kDa type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol 141:389–396, 1992PubMedGoogle Scholar
  46. 46.
    Pyke C, Ralfkiaer E, Tryggvason K, Danø K: Messenger RNA for two type IV collagenases is located in nonmalignant stromal cells in human colon cancer. Am J Pathol, in press.Google Scholar

Copyright information

© Kluwer Academic Publishers 1993

Authors and Affiliations

  • Karl Tryggvason
    • 1
  • Matti Höyhtyä
    • 1
  • Charles Pyke
    • 2
  1. 1.Biocenter and Department of BiochemistryUniversity of OuluOuluFinland
  2. 2.Finsen LaboratoryCopenhagen φDenmark

Personalised recommendations